TITLE

Vasospastic Angina in Thyrotoxicosis -- Case Reports

AUTHOR(S)
Nakano, Takeshi; Konishi, Tokuji; Takezawa, Hideo
PUB. DATE
September 1987
SOURCE
Angiology;Sep1987, Vol. 38 Issue 9, p717
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We encountered 2 patients with thyrotoxicosis accompanied at its onset by progressive angina. The ST segment was elevated in one patient and depressed in the other patient during the spontaneous attacks. Coronary arteriographic findings were normal during control, and spasm was induced by ergonovine. No patients had chest pain even without antianginal medication after successful treatment of thyrotoxicosis. The coronary artery may become sensitive to spasm during thyroid hormone excess even in cases without significant coronary artery disease and previous chest pain.
ACCESSION #
16352228

 

Related Articles

  • Cold Pressor Test and Variant Angina. Kawano, Tomoki; Okabe, Masanori; Arakawa, Kikuo // Angiology;Jul1983, Vol. 34 Issue 7, p429 

    A transient complete coronary occlusion due to spasm was induced by the cold pressor test in a 51-year-old man with variant angina. Arteriography before the test revealed a normal left coronary artery and only minor irregularities of the mid-portion of the right coronary artery. Three minutes...

  • Prinzmetal's angina.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1893 

    A reference entry for the medical term "Prinzmetal's angina," another word for variant angina, is presented.

  • Stress tests: How to make a calculated choice. Breen, Dennis P. // Journal of Family Practice;Apr2007, Vol. 56 Issue 4, p287 

    The article focuses on the study that investigates on how to find out pretest probability of coronary artery diseases (CAD) in patients with chest pain on the basis of age, sex, pain characteristics and cardiovascular risk factors. According to the author, coronary angiography is a suitable...

  • PRELIMINARY INVESTIGATION OF PHENELZINE IN THE MANAGEMENT OF ANGINA PECTORIS. Ende, Milton // Angiology;Feb1960 Part 2, Vol. 11 Issue 1, p81 

    Twenty patients with angina, pectoris of varying degrees of severity were treated with phenelzine for a period of 3 months. The dosage of phenelzine in all cases was 15 mg three times daily. Six of the 20 patients experienced complete remission of symptoms, in another 11 patients, the frequency...

  • STUDIES ON A NEW CORONARY VASODILATOR; l-CHLORO-2,3-PROPANEDIOL DINITRATE. Burgison, Raymond M.; Lu, Gordon G.; Cowley, R. Adams; Krantz Jr., John C. // Angiology;Sep1962, Vol. 13 Issue 9, p412 

    Focuses on the development of a new coronary vasodilator, 1-chloro-2,3-propanediol dinitrate, for the treatment of angina pectoris. Capacity of the compound to provide a longer duration of vasodilation with less concomitant side-effects; Materials and methods for the development of the new...

  • TREATMENT OF ANGINA PECTORIS WITH A NEW CORONARY VASODILATOR, ISOSORBIDE DINITRATE SUBLINGUAL (ISORDIL SUBLORAL). Smith Sr., Arthur L. // Angiology;Sep1962, Vol. 13 Issue 9, p425 

    Focuses on the use of the coronary vasodilator, isosorbide dinitrate sublingual, for treatment of angina pectoris. Clinical features of angina pectoris; Safety and efficacy of the drug; Recommended dosage for oral isosorbide dinitrate treatment.

  • Is it an MI? Yacone, Linda A. // RN;Jun81, Vol. 44 Issue 6, p53 

    Presents assessment guidelines for diagnosing myocardial ischemia (MI). Causes of angina pectoris resulting from MI; Steps in the nursing assessment of a patient with chest pain; Information on several causes of chest pain. INSETS: WHAT ELSE COULD IT BE?;WHAT TO TELL YOUR ANGINA PATIENTS: A...

  • Modified-Release Formulation of Trimetazidine for Exceptional Control of Angina Pectoris: Fact or Fiction. Thadani, Udho // American Journal of Cardiovascular Drugs;2005, Vol. 5 Issue 5, p331 

    Discusses the truth behind the modified-release formulation of trimetazidine for exceptional control of angina pectoris. Description of angina pectoris; Cornerstone of therapy to reduce anginal symptoms and increase angina-free exercise capacity; Dosage of antianginal drugs that should be used.

  • Treatment of Stable Angina Pectoris with Trimetazidine Modified Release in Indian Primary-Care Practice. Gupta, Rajeev; Sawhney, Jitendra P. S.; Narain, Varun S. // American Journal of Cardiovascular Drugs;2005, Vol. 5 Issue 5, p325 

    Introduction: In primary-care practice, trimetazidine is frequently used in combination with other antianginal drugs to enhance antianginal efficacy because of its metabolic mode of action. This study investigates whether a new twice-daily trimetazidine modified release formulation with improved...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics